Marrone Bio restructures
The US biopesticide company, Marrone Bio Innovations (MBI - Davis, California), is cutting back staff and refocusing its operations to reduce operating expenses. The company is shedding nearly a quarter of its staff and aims to improve efficiency in all departments. It is prioritising its R&D pipeline to focus on products that are expected to have the greatest near-term potential. "We continue to push forward with a long-term global vision for the business that remains fundamentally unchanged," says chief executive officer Dr Pam Marrone. "At the same time, we believe that reducing expenses in connection with a refocusing of our business development efforts was the prudent thing to do."